Home > Insider Trading > Filing (0001225208-14-022193)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1099800	Edwards Lifesciences Corp	EW	Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)	364316614

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1440664	D Carlyn Solomon	One Edwards Way Irvine CA 92614	Cvp, Critical Care & Vascular	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2014-10-28	39,600	$89.23	70,754	No	4	M	Direct
Common Stock	Acquisiton	2014-10-28	21,200	$85.45	91,954	No	4	M	Direct
Common Stock	Acquisiton	2014-10-28	11,850	$71.57	103,804	No	4	M	Direct
Common Stock	Disposition	2014-10-28	72,650	$118.00	31,154	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (Right to Acquire)	Disposition	2014-10-28	21,200	$85.45	21,200	$85.45
Common Stock	Employee Stock Option (Right to Acquire)	Disposition	2014-10-28	39,600	$89.23	39,600	$89.23
Common Stock	Employee Stock Option (Right to Acquire)	Disposition	2014-10-28	11,850	$71.57	11,850	$71.57

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
21,200	2013-05-09	2019-05-08	No	4	M	Direct
13,200	2012-05-12	2018-05-11	No	4	M	Direct
35,550	2014-05-14	2020-05-13	No	4	M	Direct

Footnotes

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person.
This transaction was executed in multiple trades at prices ranging from $117.69 to $118.40. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.